2017
DOI: 10.1016/j.plasmid.2017.01.004
|View full text |Cite
|
Sign up to set email alerts
|

Construction of a BioBrick™ compatible vector system for Rhodococcus

Abstract: Throughout the past decade, the field of synthetic biology has grown rapidly. By using assembly platforms such as BioBricks™, scientists can quickly and easily build gene circuits or multi-step pathways. One limitation, however, is that most of these parts were designed and characterized with Escherichia coli as the target chassis. As a consequence, there exists a lack of standardized and well characterized or BioBrick™ compatible plasmid backbones that replicate in other potential non-model chassis organisms.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 17 publications
(14 citation statements)
references
References 41 publications
0
14
0
Order By: Relevance
“…In this plasmid, gfp-parB is under the control of the Ptrc promoter (23). The Ptrc promoter has been previously shown to work in Rhodococcus (43). The plasmid pDS2 has been shown to be stable up to 60 generations (38).…”
Section: Methodsmentioning
confidence: 99%
“…In this plasmid, gfp-parB is under the control of the Ptrc promoter (23). The Ptrc promoter has been previously shown to work in Rhodococcus (43). The plasmid pDS2 has been shown to be stable up to 60 generations (38).…”
Section: Methodsmentioning
confidence: 99%
“…; ~ 10 copies per chromosome[82, 84]pGA1Derived from Corynebeacterium spp.[63, 87, 95, 96]pSR1Derived from Corynebeacterium spp.[85, 86, 88]pB264Derived from Rhodococcus sp. B264; curable; ~ 8 copies per chromosome[73]Selection markersKanamycin50 μg/mL (selection)250 μg/mL (plasmid function maintenance)[85, 88, 97]Gentamicin10 μg/mL[82]Spectinomycin100 μg/mL[82]Thiostrepton1 μg/mL[97]Chloramphenicol34 μg/mL[98, 99]Hygromycin B50 μg/mL[73]SacBNegative selection; sensitizes cell to sucrose[100, 101]PromoterspTipAInducible with thiostrepton[97, 102, 103]pAcet5× inducible with acetamide[98, 104]pBAD59× inducible with arabinose[104]pTet67× inducible with anhydrotetracycline (aTc)[104]pLPD06740247× inducible with phenol[104]p...…”
Section: Tool and Technique Development For R Opacus Engineeringmentioning
confidence: 99%
“…This standardization of methods, materials, and parts seeks to enable the rapid development of modular parts through the division of labor and characterization across the bioengineering field. Much of the work has been done in model organisms such as Bacillus subtilis [165] and E. coli [166], with some recent development in the non-model yeast Yarrowia lipolytica [167] and Rhodococcus opacus [168]. Characterizing pathways in a variety of hosts and conditions can identify situations where pathways do and do not function reliably.…”
Section: Characterization Of Engineered Pathways In Diverse Hosts Andmentioning
confidence: 99%